In plain language
Adipotide is an experimental peptide that, in animals, targets the blood supply of fat tissue and triggers fat cells to die. In obese monkeys it produced weight loss, but it also raised safety concerns, including kidney effects. There are no established human trials supporting its use, and it is a research compound only.
What it is explored for
Adipotide stands out for its unusual approach, targeting the blood supply of fat tissue rather than appetite. The idea has shown striking fat-loss results in animal models, which is why it draws curiosity, though the research is still entirely preclinical and raised real safety questions. Here is where scientific interest has been focused.
- Targeted reduction of white fat tissue
- Weight loss in obesity research models
- Studying fat-tissue blood supply
- Novel non-appetite approaches to fat loss
- Metabolic research in animal studies
These are areas of active interest and reported use, not proven outcomes. This peptide carries a limited rating, see the evidence summary below for how strong the science actually is.
How it works
Adipotide is a peptide designed to home in on the blood vessels that supply white fat tissue and to trigger cell death there.
- Vascular targeting. A targeting sequence directs the peptide to prohibitin on blood vessels feeding fat tissue.
- Induced cell death. A pro-apoptotic segment then triggers death of those vessels, reducing the fat tissue's blood supply and causing fat loss in animals.
This mechanism has been demonstrated in animals, including obese monkeys. It has not been established in controlled human trials.
Evidence summary
Evidence for adipotide is essentially preclinical. Animal studies, including obese rhesus monkeys, reported weight loss, but the work also raised safety concerns. There are no established controlled human trials, so the evidence is limited.
Reported safety & side effects
Animal studies raised safety concerns, notably effects on the kidneys at higher exposure. Human safety is not established, and there are no controlled human trials to characterize its risks.
Frequently asked
Is there human evidence for adipotide?
No established controlled human trials support adipotide. The weight-loss findings come from animal studies, including obese monkeys.
Is it safe?
Animal studies raised concerns, including kidney effects. Human safety is not established, so it cannot be considered safe for use.
How does it work?
In animals it targets the blood vessels supplying fat tissue and triggers their death, reducing fat. Whether this translates safely to humans is unknown.